# Fudan University: Not applicable (device, behavioral) study in Breast Cancer, Neoadjuvant Therapy (1024 participants)

**Score:** 30/100

| Field | Value |
|---|---|
| Sponsor | Fudan University |
| Sponsor type | Academic and hospital |
| Study | MAMMI-BB PET for Monitoring Response to Neoadjuvant Therapy in Breast Cancer |
| NCT ID | NCT07875244 |
| Phase | Not applicable (device, behavioral) |
| Status | active not recruiting |
| Conditions | Breast Cancer; Neoadjuvant Therapy; Axilla; Breast |
| Intervention types | diagnostic test |
| Target enrollment | 1024 |
| Site countries | China |
| Posted | 2026-10-15 |
| Planned start | 2019-06-27 |
| Event | Newly registered study |
| Event date | 2026-10-15 |

## Why this score
- 1024 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07875244). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.